Article Details

VistaGen Therapeutics' (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings

Retrieved on: 2025-10-11 06:55:17

Tags for this article:

Click the tags to see associated articles and topics

VistaGen Therapeutics' (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 38,732 shares of the company's stock worth $114,000 after buying an additional 13,395 shares in the last quarter.

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo